<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Surasak Chaiyasong และผู้แต่งคนอื่นๆ. (2013) Cost-Effectiveness of Alendronate and Risedronate for Primary Prevention of Fractures in Postmenopausal Women. &lt;i&gt;Isan Journal ofPharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;9&lt;/i&gt;(2), 23-36.</APA><Chicago>Surasak Chaiyasong และผู้แต่งคนอื่นๆ. "Cost-Effectiveness of Alendronate and Risedronate for Primary Prevention of Fractures in Postmenopausal Women". Isan Journal ofPharmaceutical Sciences  9 (2013):23-36.</Chicago><MLA>Surasak Chaiyasong และผู้แต่งคนอื่นๆ. Cost-Effectiveness of Alendronate and Risedronate for Primary Prevention of Fractures in Postmenopausal Women. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2013.</MLA></bibliography></xml>
